← Back to Portal 🏠 Dashboard

📚 Central Nervous System Special Senses Module L1 Bacterial Meningitis

🎯 Exam Preparation Summary

📚 Lecture Overview

This lecture covers the etiology, pathogenesis, clinical features, laboratory diagnosis, and prevention of bacterial meningitis, with a dedicated focus on Neisseria meningitidis. It highlights the critical clinical and laboratory distinctions between purulent (septic) bacterial meningitis and aseptic (viral/tubercular) meningitis. Understanding these distinctions is vital for rapid diagnosis and emergency antimicrobial intervention.


🎯 Key Concepts & Definitions


📖 Main Content

1. Etiology of Meningitis by Age Group & Clinical Setting

Meningitis causes vary according to host age, immune status, and clinical interventions:

Host Group / Setting Major Causative Organisms Key Microbiological Traits & Transmission
Neonates (<3 months) Streptococcus agalactiae (Group B) Gram-positive cocci in chains, $\beta$-hemolytic, Catalase negative. Genital tract flora.
Escherichia coli Gram-negative bacilli, lactose fermenter. Virulence factors present.
Listeria monocytogenes Gram-positive bacilli. Transplacental (<2 days) or intrapartum exposure (2–3 weeks).
Children (6 months – 5 years) Haemophilus influenzae (Type b) Gram-negative bacilli. Droplet contact. Enhanced by prior viral infection.
Infants to Young Adults Neisseria meningitidis Gram-negative diplococci. Droplet transmission via respiratory secretions.
All Ages / Elderly Streptococcus pneumoniae Gram-positive lancet-shaped diplococci. Endogenous or droplet transmission.
Special Conditions Staphylococcus epidermidis Associated with CNS shunts.
Pseudomonas aeruginosa Postoperative surgical complications.

2. Pathogenesis of Bacterial Meningitis

Bacterial invasion of the Central Nervous System follows a predictable step-by-step sequence:

  1. Nasopharyngeal Colonization: Pathogens attach to the nasopharyngeal mucosa using structures like pili and evade local IgA antibodies via IgA protease.
  2. Local Mucosal Invasion: Pathogens cross the epithelial mucosal barrier to gain access to the bloodstream.
  3. Bacteremia: Survival and multiplication within the circulation, evading host phagocytosis.
  4. CNS Entry: Pathogens cross the blood-brain barrier to enter the subarachnoid space.
  5. Meningeal Inflammation: Unchecked bacterial replication in the CSF triggers a severe inflammatory cytokine cascade.

3. Laboratory Diagnosis & CSF Differentiation

Laboratory diagnosis relies on comparing CSF parameters between health, purulent meningitis, and aseptic meningitis.

Laboratory Parameter Normal Range Purulent (Bacterial) Meningitis Aseptic (Viral/TB) Meningitis
Macroscopic Appearance Clear Turbid / Purulent Clear / Slightly cloudy
Cell Count & Type 0–5 cells/mm³ (Lymphocytes) 5 – 20,000 cells/mm³ (Polymorphs/PMNs) 5 – 2,000 cells/mm³ (Lymphocytes)
CSF Glucose 50–100 mg/dL Markedly Reduced Normal (Viral) / Reduced (TB)
CSF Protein 15–50 mg/dL Markedly Elevated Mildly Raised

Empirical Antibiotic Treatment


4. Special Focus: Neisseria meningitidis (Meningococcus)

General Features

Determinants of Pathogenicity

Clinical Presentations

Carrier Detection vs. Diagnostic Culture

Prevention Strategy

  1. Polysaccharide Vaccines: Available in tetravalent forms; ineffective in children <2 years; produces short-term immunity without reducing nasopharyngeal carriage.
  2. Conjugate Vaccines: Protein-coupled capsular antigen; induces T-cell-dependent memory, effective in infants under 2 years, and reduces carriage.
  3. Chemoprophylaxis: Administered to close/household contacts to eradicate carriage:
    * First-line: Rifampin
    * Adults: Ciprofloxacin
    * Children: Ceftriaxone

📊 Visual Learning

flowchart TD A[Nasopharynx Colonization] --> B[Mucosal Barrier Invasion] B --> C[Bacteremia in Blood] C --> D[Cross Blood Brain Barrier] D --> E[Replication in Subarachnoid Space] E --> F[Meningeal Inflammation]
mindmap root("N meningitidis Factors") "Polysaccharide Capsule" "Antiphagocytic function" "Pili and OMP" "Adhesion to mucosa" "IgA Protease" "Cleaves host IgA" "Endotoxin LPS" "Petechial rash and shock"
graph TD A[CSF Analysis] --> B[Purulent Bacterial] A --> C[Aseptic Viral] B --> D[High PMN Count] B --> E[Low Glucose] B --> F[High Protein] C --> G[High Lymphocytes] C --> H[Normal Glucose] C --> I[Mild High Protein]

💡 Important Points to Remember


⚠️ Common Exam Questions & Traps

Common Exam Traps & Tricks

  1. The Nasopharyngeal Swab Trap:
    * Exam Trick: A question asks for the diagnostic specimen to confirm active meningococcal meningitis in a patient presenting with high fever and neck stiffness. Option A is a Nasopharyngeal swab.
    * Trap: Students pick the swab.
    * Fact: Nasopharyngeal swabs are ONLY used for carrier detection surveys. Diagnostic confirmation requires CSF or blood culture.

  2. CSF Differentiation Trick:
    * Exam Trick: Presenting CSF values showing elevated protein, elevated cell count with 85% lymphocytes, and normal glucose.
    * Trap: Diagnostic choice lists S. pneumoniae or N. meningitidis.
    * Fact: Normal glucose with lymphocytic predominance means it is aseptic/viral meningitis, NOT bacterial.

  3. Vaccine Selection in Infants:
    * Exam Trick: Asking which vaccine type to administer to a 14-month-old infant for long-term protection against serogroups A, C, Y, W-135.
    * Trap: Choosing the standard polysaccharide vaccine.
    * Fact: Pure polysaccharide vaccines are non-immunogenic in children <2 years. You MUST select the Polysaccharide-Protein Conjugate Vaccine.

  4. Listeria Onset Timing:
    * Exam Trick: Differentiating early-onset vs. late-onset neonatal Listeria infections.
    * Fact: Early onset (<2 days of life) occurs via transplacental transmission. Late onset (2–3 weeks) occurs via contact during/after delivery.


📝 Quick Review Checklist

I can differentiate bacterial and viral meningitis based on CSF glucose, protein, and cell counts.
I know the top 3 causes of neonatal bacterial meningitis.
I can list all 5 major virulence factors of Neisseria meningitidis and their functions.
I understand why conjugate vaccines are required for children under 2 years of age.
I know which culture media (Thayer-Martin) and swab type (West swab) are used to detect meningococcal carriers.
I can name the antimicrobial agents used for empiric meningitis treatment and close-contact chemoprophylaxis.
I can identify the features of Waterhouse-Friderichsen syndrome.